# Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease

> **NCT03022201** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Parkinson's Disease,Idiopathic

## Interventions

- **DRUG:** DA-9701
- **DRUG:** Domperidone
- **DRUG:** Placebo domperidone
- **DRUG:** Placebo DA-9701

## Key facts

- **NCT ID:** NCT03022201
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022201, "Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03022201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*